OtoNexus Medical Technologies
Seattle, US · Delaware corporation · 3 known investors
Find your way into OtoNexus Medical Technologies
Sign up to see every warm intro you have to OtoNexus Medical Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OtoNexus Medical Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
HB
Harris BrodyBoard director
RF
Rhonda F. RhyneBoard director
MR
Marion R. FooteBoard director
Investors · 3
Dellin InvestmentsreportedPhiladelphia
How we know: a partner's Signal profile · Not right? Tell us
Keiretsu CapitalreportedSeattle · $100K – $500K
How we know: funding news · press coverage · Not right? Tell us
Keiretsu ForumreportedSan Francisco East Bay · $250K – $2M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$44.3M disclosed across 5 rounds · 2015–2022
▶$12.9MraisedFeb 2024 · 114 investors · Other Health CareRule 506(b)
▶$12.9MraisedFeb 2024 · 114 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark A. MoehringDirector
- Marion R. FooteDirector
- George A. GatesExecutive Officer, Director
- Caitlin CameronExecutive Officer, Director
- Harris BrodyDirector
- Offering amount
- $15M
- Amount sold
- $12.9M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedJan 2022 · 21 investors · Other Health CareRule 506(b)
▶$1.9MraisedJan 2022 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Harris BrodyDirector
- Rhonda F. RhyneDirector
- Caitlin CameronExecutive Officer, Director
- Marion R. FooteDirector
- George A. GatesExecutive Officer, Director
- Mark A. MoehringDirector
- Offering amount
- $5M
- Amount sold
- $1.9M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$19.5MraisedJun 2021 · 190 investors · Other Health CareRule 506(b)
▶$19.5MraisedJun 2021 · 190 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marion R. FooteDirector
- Caitlin CameronExecutive Officer, Director
- George A. GatesExecutive Officer, Director
- Rhonda F. RhyneDirector
- Harris BrodyDirector
- Mark A. MoehringDirector
- Offering amount
- $28.2M
- Amount sold
- $19.5M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.8MraisedJan 2017 · 80 investors · Other Health CareRule 506(b)
▶$7.8MraisedJan 2017 · 80 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Rhonda F. RhyneDirector
- Mark A. MoehringDirector
- Marion R. FooteDirector
- Caitlin CameronExecutive Officer, Director
- George A. GatesExecutive Officer, Director
- Harris BrodyDirector
- Offering amount
- $9.2M
- Amount sold
- $7.8M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedJun 2016 · 54 investors · Other Health CareRule 506(b)
▶$2.2MraisedJun 2016 · 54 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark A. MoehringDirector
- Harris BrodyDirector
- Rhonda F. RhyneDirector
- George A. GatesExecutive Officer, Director
- Marion R. FooteDirector
- Caitlin CameronExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.2M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are OtoNexus Medical Technologies's investors?
- OtoNexus Medical Technologies's investors include Dellin Investments, Keiretsu Capital, Keiretsu Forum.
- How much funding has OtoNexus Medical Technologies raised?
- OtoNexus Medical Technologies has disclosed $44.3M raised across 5 rounds.
- Where is OtoNexus Medical Technologies headquartered?
- OtoNexus Medical Technologies is headquartered in Seattle, US.

